Investors

Date of Board Meeting Purpose Details
13.02.2024 Unaudited Financial Results Inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine month ended December 31, 2023.
09.11.2023 Unaudited Financial Results Inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2023.
10.08.2023 Unaudited Financial Results Inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2023.
04.07.2023 Notice of Board meeting for Considering and approving recommendation of final dividend and preferential issue of warrants Inter-alia to transact the following 1)To consider and approve proposal for fund raising by way of issue of share warrants through ‘Preferential Issue’ subject to such regulatory or statutory approvals and the approval of the shareholders of the Company as may be required; 2) To consider and recommend dividend, if any, on equity shares of the Company for the financial year ended March 31, 2023 (FY 2022-23).
23.05.2023 Audited Financial Results Inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2023.
03.02.2023 Unaudited Financial Results Inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine month ended December 31, 2022.
10.11.2022 Unaudited Financial Results Inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2022.
03.08.2022 Unaudited Financial Results and Recommendation of a Dividend, if any Inter alia to consider & approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2022 and to consider & recommend a dividend, if any, on equity shares of the company for the financial year ended March 31, 2022.
12.05.2022 Audited Financial Results Inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2022.
28.01.2022 Unaudited Financial Results Inter alia, to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2021.
29.10.2021 Unaudited Financial Results Inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2021.
29.07.2021 Unaudited Financial Results and Recommendation of a Dividend, if any Inter alia to consider & approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2021 and to consider & recommend a dividend, if any, on equity shares of the company for the financial year ended March 31, 2021.
28.05.2021 Audited Financial Results Inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2021.
21.01.2021 Unaudited Financial Results Inter alia, to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2020.
23.10.2020 Unaudited Financial Results Inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2020.
29.07.2020 Unaudited Financial Results and Recommendation of a Dividend, if any Inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2020 and to consider recommendation of a dividend, if any, on equity shares of the company for the financial year ended March 31, 2020.
10.06.2020 Audited Financial Results Inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2020.
22.01.2020 Unaudited Financial Results Inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine-months ended December 31, 2019.
23.10.2019 Unaudited Financial Results Inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2019.
25.07.2019 Unaudited Financial Results and Recommendation of a Dividend, if any Inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the first quarter ended June 30, 2019 and to consider recommendation of a dividend, if any, on equity shares of the company for the financial year ended March 31, 2019.
11.05.2019 Audited Financial Results and Recommendation of a Dividend, if any Inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2019 and to consider recommendation of a dividend, if any, on equity shares of the company for the financial year ended March 31, 2019.
22.10.2018 Unaudited Financial Results Inter alia, to consider, approve and take on record the Unaudited Financial Results for the quarter and half year ended September 30, 2018.
27.07.2018 Unaudited Financial Results Inter alia, to consider, approve and take on record the Unaudited Financial Results for the quarter ended June 30, 2018.
20.07.2020 Audited Financial Results and Recommendation of a Dividend, if any Inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2020 and to consider recommendation of a dividend, if any, on equity shares of the company for the financial year ended March 31, 2020.
11.05.2018 Audited Financial Results and Recommendation of a Dividend, if any Inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2018 and to consider recommendation of a dividend, if any, on equity shares of the company for the financial year ended March 31, 2018.
24.01.2018 Unaudited Financial Results Inter alia, to consider, approve and take on record the Unaudited Financial Results for the quarter ended December 31, 2017.
11.11.2017 Unaudited Financial Results Inter alia, to consider, approve and take on record the Unaudited Financial Results for the quarter and half-year ended September 30, 2017.
11.08.2017 Notice of Board Meeting to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2017 and to fix up the date of Annual General Meeting Inter alia to consider, approve and take on record the Unaudited Financial Results for the quarter ended June 30, 2017; fix up the date, time and venue for convening the 25th Annual General Meeting (“AGM”) of the Company; and note the closure of the register of members and share transfer books for the purpose of AGM and payment of dividend, if declared at the said AGM .
23.05.2017 Audited Financial Results and Recommendation of a Final Dividend, if any Inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2017 and to consider recommendation of a final dividend, if any, on equity shares of the company for the financial year ended March 31, 2017.
31.01.2017 Interim Dividend Consideration of declaration of interim dividend, if any, for the financial year ending March 31, 2017
31.01.2017 Unaudited Financial Results Inter alia, to consider, approve and take on record the Unaudited Financial Results for the quarter and nine-months ended December 31, 2016.
26.11.2016 Unaudited Financial Results Inter alia, to consider, approve and take on record the Unaudited Financial Results for the quarter and half-year ended September 30, 2016
19.08.2016 Unaudited Financial Results Inter alia, to consider, approve and take on record the Unaudited Financial Results for the quarter ended June 30, 2016
25.05.2016 Audited Financial Results and Recommendation of Dividend, if any Inter alia to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2016 and to recommend dividend, if any.
08.02.2016 Unaudited Financial Results Inter alia, to consider, approve and take on record the Unaudited Financial Results for the quarter & nine-months ended December 31, 2015
09.11.2015 Unaudited Financial Results Inter alia, to consider, approve and take on record the Unaudited Financial Results for the quarter and half-year ended September 30, 2015.
12.08.2015 Un-audited Financial Results Inter alia, to consider, approve and take on record the Unaudited Financial Results for the quarter ended June 30, 2015
27.05.2015 Audited Financial Results and Recommendation of Dividend Inter alia to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2015 and to recommend dividend, if any
14.02.2015 Un-Audited Financial Results Inter alia, to consider, approve and take on record the Unaudited Financial Results for the quarter/nine-months ended December 31, 2014
14.11.2014 Unaudited Financial Results Inter alia, to consider, approve and take on record the Unaudited Financial Results for the quarter/half year ended September 30, 2014
04.08.2014 Unaudited Financial Results Inter alia, to consider, approve and take on record the Unaudited Financial Results for the quarter ended June 30, 2014
20.05.2014 Audited Financial Results to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2014 and to recommend dividend, if any
08.02.2014 Un-audited Financial Results Inter alia, to consider, approve and take on record the Un-audited Financial Results for the quarter/nine months ended December 31, 2013

Genus Initiates Smart Meter Installation in Uttarakhand for Enhanced Power Efficiency

Genus becomes first and only Indian Company to get BIS certification for Gas Meters